Olympiad Research’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Olympiad Research’s Portfolio FPRX Stock Details FPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-79,449	Closed	-$2.99M	–	281
2021 Q1	$2.99M	Buy	+79,449	New	+$1.98M	1.28%	23

Olympiad Research's FPRX Position: Q2 2021 in Review

Olympiad Research sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 79,449 shares — an estimated $2.99M sold.

Olympiad Research first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $2.99M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

Olympiad Research reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
Olympiad Research sold 79,449 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $2.99M.
Olympiad Research first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
Olympiad Research's Five Prime Therapeutics, Inc. position peaked at $2.99M in Q1 2021.
0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on Olympiad Research's 13F filing for Q2 2021, filed 4 Aug 2021.